Diagnostics

IAVI and IPD Sign Agreement Formalizing Collaboration to Advance Vaccine Development, Manufacturing, and Access in Africa

Agreement signed to establish collaboration between IAVI and IPDNew partnership aims to accelerate vaccine development and manufacturing for priority pathogens…

2 weeks ago

Dr. Alan Bauman to Debut Virtual AI Avatar ‘Twin’ in Collaboration with AI Wellness at A4M Anti-Aging Conference

BOCA RATON, Fla., Dec. 12, 2024 /PRNewswire/ -- Renowned hair restoration physician and founder of Bauman Medical, Dr. Alan J.…

2 weeks ago

New Lunit Study Demonstrates Universal AI Model for Analysis of Immunohistochemistry Images

Research in npj Precision Oncology highlights multi-cohort training approach and accurate analysis of unseen immunohistochemistry data SEOUL, South Korea, Dec.…

2 weeks ago

DCN Dx Announces 2025 Basic Lateral Flow Training Course Dates

Industry-Leading Training on Lateral Flow Assay Development Returns with New Opportunities CARLSBAD, Calif., Dec. 12, 2024 /PRNewswire/ -- DCN Dx, specializing…

2 weeks ago

Chung-Ang University Researchers Unveil the Biogenesis and Role of Transfer RNA Fragments in Cancer Progression

Study reveals that 5'-tRNAGly(GCC) is a key regulator of gene expression and a potential therapeutic target in cancer SEOUL, Dec.…

2 weeks ago

Axtria Leads Frost & Sullivan’s First Pharmaceutical Commercialization Solutions and Services Industry Radar Report

BERKELEY HEIGHTS, N.J., Dec. 12, 2024 /PRNewswire/ -- Axtria Inc., a global cloud software and data analytics company for the…

2 weeks ago

VolitionRx Appoints LifeSci Advisors as Investor Relations Consultants

Volition to participate in the upcoming 14th Annual LifeSci Partners Corporate Access Event on January 15th, 2025 at the Beacon…

2 weeks ago

Myant to Reveal Award-Winning Health Platform Driven by Advanced Materials and AI at CES 2025

TORONTO, Dec. 12, 2024 /PRNewswire/ -- Myant Corp. announced it will unveil the future of human-AI interfaces at CES 2025,…

2 weeks ago

Exagen Inc. Achieves Key Milestone with 1,000,000th Patient Tested by AVISE® CTD

The milestone demonstrates AVISE CTD’s value and adoption within the rheumatologic community, clearly demonstrating superior laboratory testing for improved patient…

2 weeks ago

Lumos Pharma and Double Point Ventures Announce Successful Completion of Tender Offer and Double Point Ventures’ Acquisition of Lumos Pharma

AUSTIN, Texas and GREENWICH, Conn., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO) (“Lumos Pharma” or the “Company”),…

2 weeks ago